News Archive
SiFive Hits $3.65B Valuation in Nvidia-Backed Round for Open AI Chips
The RISC-V pioneer is no longer just an IP licensor. It wants to sit inside data-center CPUs.
Court Rules Ad Platforms Liable When AI Has 'Ultimate Authority' Over Fraud
A Northern District of California ruling hands regulators a new enforcement lever. Automated ad pipelines just got more expensive to run.
Snap Cuts 1,000 Jobs as AI Now Writes 65% of Its Codebase
The layoffs are real. The 65% number is the one every other CEO is about to cite.
Wayve Secures $60M from Qualcomm, AMD and Arm for Mapless Self-Driving
Three chip giants just signed the same check. The message: the self-driving winner will not need HD maps.
Novo Nordisk Ties Up with OpenAI to Embed AI Across Pharma Stack
Discovery, trials, manufacturing, supply chain, commercial. One of the broadest enterprise AI integrations ever announced.
Humans Still Beat the Best AI Agents on Complex, Open-Ended Tasks
A new Nature study finds that state-of-the-art agent systems collapse on multi-step reasoning that seasoned scientists handle routinely.
The Arena Gap: Inside the 2.7% That Separates U.S. and Chinese Frontier Models
A close look at what 39 Arena points actually means, where each lab is winning, and the policy gears now turning in Washington and Beijing.
ASML Raises 2026 Outlook as Customers Accelerate AI-Driven Expansion
The EUV monopolist just told investors the AI buildout has another leg. Its order book agrees.
Samsung Teases 2026 AI TV Lineup at European Tech Seminar
The on-device AI race is coming to your living room. Samsung wants to set the baseline.
Spektr Closes $20M Series A to Automate Financial Compliance with AI
Copenhagen-based Spektr wants to replace the slowest, most expensive workflow in finance.
DeepX Preps IPO With Low-Power On-Device AI Chip Pitch
South Korea's DeepX is taking the edge-AI thesis public. The timing is deliberate.
Courts Levy $145K+ in Sanctions Against Lawyers for AI Citation Errors
Q1 2026 sanctions are already at record levels. Judges have stopped treating hallucinations as novelty.